Biologic therapy in psoriasis: perspectives on associated risks and patient management. [electronic resource]
Producer: 20120920Description: 153-68 p. digitalISSN:- 1203-4754
- Adalimumab
- Alefacept
- Algorithms
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Biological Products -- adverse effects
- Canada
- Dermatologic Agents -- adverse effects
- Etanercept
- Humans
- Immunoglobulin G -- adverse effects
- Infliximab
- Psoriasis -- drug therapy
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Recombinant Fusion Proteins -- adverse effects
- United States
- Ustekinumab
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.